In a study, CUR was found to have the capacity to cause protein kinase D1 (PKD1) activation, which can lead to the weakening of the oncogenic signaling via MAPK and β-catenin [324] and subsequent suppression of prostate cancer development [324]. The gene discussed is PKD1; the disease is Familial prostate cancer.